Study: Aspirin may help reduce cancer deaths

LONDON An Oxford University study discovered that daily doses of aspirin can cut the risk of death from the most common forms of cancer including colon, lung and gastro intestinal cancers.

"What we found was, in the trials where people were taking aspirin for four, five , six, seven years on average, the risk of dying from cancer was reduced by about 25 percent," said Dr. Peter Rothwell, the author of the Oxford study.

Doctors caution that there are potentially dangerous side effects for some patients, including bleeding, stomach bleeding and stroke.

The study was published Tuesday in the medical journal Lancet.

The Associated Press contributed to this report.